#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Demyelination Acute graft versus host disease in liver Bronchopulmonary dysplasia Ovarian cancer stage III Pulmonary sarcoidosis NTRK gene fusion overexpression Brain injury Nephroblastoma Cutaneous T-cell lymphoma refractory Adenomatous polyposis coli Polymyositis Immune thrombocytopenia Alagille syndrome Oesophageal adenocarcinoma stage II Stevens-Johnson syndrome More trials…

    Learn about Rare Diseases

    Atypical haemolytic uraemic syndrome – Diagnostics Paroxysmal nocturnal haemoglobinuria – Diagnostics Basal cell naevus syndrome – Trials in Disease Glomerulonephritis membranoproliferative – Basic Information Leiomyosarcoma recurrent – Diagnostics Netherton’s syndrome – Life with Disease Chronic granulomatous disease – Life with Disease Soft tissue sarcoma – Basic Information Cytokine release syndrome – Diagnostics Hereditary optic atrophy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Crinecerfont Doxycycline Monohydrate Molgramostim Hyoscine Butylbromide Brimonidine PHENTOLAMINE MESILATE SODIUM SULFIDE NONAHYDRATE Lufepirsen Isoniazid Sabestomig The-630 INSULIN DETEMIR Lithium Tezacaftor Ceftazidime Pentahydrate Linrodostat Mesilate Ritonavir Calcipotriol Nalbuphine Hydrochloride Rimegepant More therapies…

    Learn about Your Condition

    Brain injury Post-acute COVID-19 syndrome Polycystic liver disease Endocrine disorder Acute kidney injury Myelofibrosis Skin neoplasm excision Small for dates baby Neuromyopathy Ovarian granulosa cell tumour Leukaemia Tumour thrombosis Familial hypertriglyceridaemia Univentricular heart Vulvovaginal pain More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mental Disorders

  • Study on the Effect of Ketamine and Esketamine in Patients with Major Depressive Disorder After First-Line Treatment Failure

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Agomelatine
    • Amitriptyline Hydrochloride
    • Atomoxetine
    Austria Germany Greece Italy Spain

  • Study on the Safety and Effects of ACI-24.060 for Patients with Early Alzheimer’s Disease and Adults with Down Syndrome

    Recruiting

    1 1 1
    Investigated Drugs:
    • Pal1-15 Acetate
    • Izaflortaucipir (18F)
    • Florbetaben (18F)
    Spain

  • Study on Dexamethasone for Patients with Moderate to Severe Depression: Evaluating Its Effectiveness with Mirtazapine, Citalopram, and Nortriptyline

    Recruiting

    3 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Betamethasone Sodium Phosphate Ph. Eur
    • Nortriptyline
    • Pregabalin
    Denmark

  • Study on the Effectiveness of Reconsolidation Therapy with Propranolol for Patients with Severe Post-Traumatic Stress Disorder

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Post-traumatic stress disorder
    Investigated Drugs:
    • Propranolol Hydrochloride
    Belgium

  • Study on Minocycline and Celecoxib for Patients with Major Depressive Disorder Not Responding to Antidepressants

    Recruiting

    3 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Minocycline
    • Celecoxib
    Belgium

  • Study on Melatonin and Low-Dose Quetiapine for Patients with Psychiatric Disorders and Insomnia

    Recruiting

    4 1 1
    Investigated Diseases:
    • Insomnia
    Investigated Drugs:
    • Melatonin
    • Quetiapine
    Denmark
Previous Page
1 … 16 17 18 19 20 … 40
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!